Article

Sex-specific predictive values of biomarkers for immunotherapy efficacy in lung adenocarcinoma

2020-10-27

Abstract excerpt

It remains a challenge to accurately predict patient responses to tumor immunotherapy, although various biomarkers have been proposed to predict patient responses to anti-PD-1 therapy. Here by integrating genomic, transcriptomic, proteomic and clinical phenotype data from three immunotherapeutic cohorts and a multiple-dimensional dataset of The Cancer Genome Atlas (TCGA) project, we uncovered a profound effect of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ab39916c-9661-5703-aec8-c14133388ede
DOI: 10.1101/2020.10.26.356220

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Sex-specific predictive values of biomarkers for immunotherapy efficacy in lung adenocarcinomaDOI 10.1101/2020.10.26.356220Read

Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune EvasionSemantic proximity Read

Sex-biased molecular differences in lung adenocarcinoma are ethnic and smoking specific.Semantic proximity Read

Somatic mutational landscape reveals mutational signatures and significantly mutated genes of cancer immunotherapeutic outcome and sex disparities.Semantic proximity Read

Identification of mutational signature for lung adenocarcinoma prognosis and immunotherapy prediction.Semantic proximity Read

Sex-differential responses to immune checkpoint inhibitors across the disease continuum unified by tumor mutational burden.Semantic proximity Read

Sex-based differences in lung cancer susceptibility and molecular genetics in the 2020sSemantic proximity Read

Sex-specific differences in immunogenomic features of response to immune checkpoint blockadeSemantic proximity Read

Sex Differences in the Cancer ProteomeSemantic proximity Read

Prognostic value of immune-related genes and comparative analysis of immune cell infiltration in lung adenocarcinoma of different gendersSemantic proximity Read

Identification of a Cancer Testis Antigen-Associated Six-Gene Signature in Lung Adenocarcinoma for the Prediction of Survival and Response to Immune-Checkpoint InhibitorsSemantic proximity Read

Genetic and Immune Profiles of Solid Predominant Lung Adenocarcinoma Reveal Potential Immunotherapeutic Strategies.Semantic proximity Read

Antithetical impacts of deleterious LRP1B mutations in non-squamous and squamous NSCLCs on predicting benefits from immune checkpoint inhibitor alone or with chemotherapy over chemotherapy alone: retrospective analyses of the POPLAR/OAK and CHOICE-01 trials.Semantic proximity Read